SCHEMBL14864844

SCHEMBL14864844

CC(C)CCC[C@@H](C)[C@H]1CC[C@@]2(C)[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RORC P51449 7/20 0.66
▸ OSBP P22059 5/20 0.66
▸ OSBP2 Q969R2 3/20 0.66
▸ USP2 O75604 2/20 0.66
▸ LMNA P02545 1/20 0.66
▸ ABCB1 P08183 1/20 0.66
▸ CYP46A1 Q9Y6A2 1/20 0.66
▸ RORA P35398 3/20 0.56
▸ NPC1L1 Q9UHC9 3/20 0.56
▸ MEN1 O00255 1/20 0.56
▸ ALOX15 P16050 1/20 0.56
▸ KMT2A Q03164 1/20 0.56
▸ GRIN1 Q05586 3/20 0.55
▸ GRIN2A Q12879 3/20 0.55
▸ GPR183 P32249 1/20 0.55
▸ NR1H3 Q13133 3/20 0.55
▸ CRYAB P02511 1/20 0.52
▸ HMGCR P04035 1/20 0.52
▸ ITGB3 P05106 1/20 0.52
▸ ITGAV P06756 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31305863 0.91 RORC (0.62) RORCOSBPOSBP2USP2LMNA
SCHEMBL10105385 0.91 RORC (0.62) RORCOSBPOSBP2USP2LMNA
SCHEMBL22150297 0.90 RORC (0.61) RORCOSBPOSBP2USP2LMNA
SCHEMBL26668061 0.85 NR1H3 (0.67) RORCOSBPOSBP2USP2LMNA
SCHEMBL14602524 0.83 POLA1 (0.53) RORCOSBPOSBP2USP2LMNA
SCHEMBL18167508 0.83 RORC (0.58) RORCOSBPOSBP2USP2LMNA
SCHEMBL14641136 0.83 POLA1 (0.53) RORCOSBPOSBP2USP2LMNA
SCHEMBL22032747 0.83 RORC (0.58) RORCOSBPOSBP2USP2LMNA
SCHEMBL18167509 0.83 RORC (0.58) RORCOSBPOSBP2USP2LMNA
SCHEMBL13391627 0.83 POLA1 (0.53) RORCOSBPOSBP2USP2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9173839-B2 Anionic lipids and lipid nano-structures and methods of producing and using same THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA (US) 2015-11-03 — — US disclosed
US-20130243688-A1 ANIONIC LIPIDS AND LIPID NANO-STRUCTURES AND METHODS OF PRODUCING AND USING SAME UNIV OKLAHOMA (US) 2013-09-19 — — US disclosed
US-8420118-B2 Anionic lipids and lipid nano-structures and methods of producing and using same THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA (US) 2013-04-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130243688-A1 ANIONIC LIPIDS AND LIPID NANO-STRUCTURES AND METHODS OF PRODUCING AND USING SAME SGMS2, SGMS1, PHOSPHO1 RORC 2485/4885OSBP 444/4885OSBP2 212/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback